BIT's 13th Annual World Cancer Congress-2020(WCC-2021)
Rescheduled Notice
With cases of Covid-19 reaching new heights in the world, some states have to adapt rapidly with their rules and regulations. After seeking advice from the some agency and venue hotel in Lisbon, also considering the traffic control and epidemic prevention, the committee must admit this July is not a good time for holding an event. So after serious consideration, the organizing committee decides to postpone this meeting to next July at Lisbon, Portugal. Sincerely hope you can understand such a demanded action.

Apart from protecting our participants, rescheduling non-essential gathering and travel also aims to contain the spread of coronavirus disease and protect the health system which will otherwise be overwhelmed. Thank you very much for your understanding in the complex situation.

Event Committee
Introduction to WCC-2021

BIT's 13th Annual World Cancer Congress(WCC-2021) will be held during July 20-22, 2021 in Lisbon, Portugal.
WCC-2021 is a dedicated event where you will have the opportunity to learn about new developments in the field of cancer research, cancer therapies, and new drug trials, share aspects of your own work by submitting an oral presentation or poster. With the participation of outstanding international experts, we hope productive discussions would stimulate new creative ideas to translate new discoveries into better practice and application. We hope your participation would contribute to your professional development and relationships. Wish you enjoy the conference.

Keynote Speakers
Dr. Jukka H. Meurman
Professor, University of Helsinki & Helsinki University Hospital, Finland
Dr. Rossitza Lazova
Director of Dermatopathology in San Jose, California Skin Institute, USA
Renowned Speakers of WCC-2021
Dr. Yi Sun, Professor, University of Michigan, Comprehensive Cancer Center, USA Dr. Sinerik Ayrapetyan, Professor, UNESCO Chair-Life Sciences International Postgraduate Educational Center, Coordinator of UNESCO/UNITWIN Interregional Network on PhD Education and Research in Biophysics, Biotechnology and Environmental Health, Armenia Dr. Zoe S. Walters, Lecturer & Programme Lead , Faculty of Medicine, University of Southampton, UK
Dr. Ioannis Papasotiriou, Medical Director, Director, R.G.C.C. INTERNATIONAL GmbH, Switzerland Dr. Anna Juncker-Jensen, Senior Scientist, NeoGenomics, USA Dr. Shaul Mordechai, Professor & Head, Biomedical Spectroscopy, Ben Gurion University, Israel
Dr. Timothy N Hembree, Assistant Professor, University of South Florida, USA Dr. Femida Gwadry-Sridhar, CEO & Founder, Pulse Infoframe Inc., Canada Dr. Robert L. Bard, Director, Bard Cancer Diagnostics, USA
Dr. Birgit Leibbrand, Medical Director, Salzetalklinik, Onkologische Rehabilitation, Germany Dr.  Iouri Borissevitch, Full Professor, Universidade de São Paulo, Brazil Dr. Mohamed El-Sheemy, Research Development, Lincoln County Hospital, UK
Dr. Paul De Leyn, Chairman, UZ Leuven, Belgium Dr. Mitsuru Sasako, Special Consultant Surgeon Yodogawa Christian Hospital, Japan Dr. Katya Ravid, Professor, Boston University School of Medicine, USA
Dr. Weiping Zhang, Director, The Third Affiliated Hospital of Zhejiang Chinese Medical University, China Dr. Hillary Klonoff-Cohen, Professor, University of Illinois Urbana-Champaign, USA Dr. Chi-Min Shih, General Pathologist Chia-Yi Hospital, Ministry of Health and Welfare, Taiwan
Dr. Michael Friedrich, Head, HELIOS Hospital, Germany Dr. Tomiyo Nakamura, Professor, Ryukoku University, Japan Dr. Asha Ramsakal, Associate Professor, H. Lee Moffitt Cancer Center, USA
Introduction to Lisbon

Lisbon is the capital and the largest city of Portugal. With an estimated population of 505,526 within its administrative limits in an area of 100.05 km, Lisbon's urban area extends beyond the city's administrative limits with a population of around 2.8 million people, being the 11th-most populous urban area in the European Union. About 3 million people live in the Lisbon Metropolitan Area, including the Portuguese Riviera, (which represents approximately 27% of the country's population). It is mainland Europe's westernmost capital city and the only one along the Atlantic coast. Lisbon lies in the western Iberian Peninsula on the Atlantic Ocean and the River Tagus. The westernmost areas of its metro area form the westernmost point of Continental Europe, which is known as Cabo da Roca, located in the Sintra Mountains.

Exhibition and Poster

As part of the BIT's 13th Annual World Cancer Congress (WCC-2021), an exhibition space will provide a unique opportunity for exhibitors to showcase their products and services to participants with interests in all areas of cancer. Developed to offer comfort to delegates while maximizing exhibitor exposure, the coffee breaks and poster sessions will all take place in the exhibition area promoting frequent and repeated opportunities for delegates to visit the exhibits.

Exhibitors' advantages
• The exhibition will be visited by participants of the conference it means by your authentic target group from China and other countries.
• The exhibitors have the opportunity to present their exhibits more detailed, and have the opportunity for longer discussion with inquiring visitors – in most cases specialists – than during session discussions.


Exhibition Date:
Set-up date: July 19, 2021
Show dates: July 20-22, 2021 09:00-18:00
Place: Lisbon, Portugal

Hosting Organization

BIT Group Global Ltd.

Supporting Organization
The Society of Supportive Care in Oncology

International Honorary Chairmen

Dr. Vladimir Lazar
Chief Scientific and Operating Officer
WIN Consortium, France

Dr. Ashok Srivastava
Chief Executive Officer & Chief Medical Officer, ClinFomatrix, Cure Pharmaceuticals, Inc, USA

Contact Us

Contact Us:
Company Name: NOVA SILK ROAD SARL, Company Address: 37 rue des Mathurins, Paris, France
Copyright © 2008-2020 BIT Congress